You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 2, February 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Liver Transplantation
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Immunology
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ocular Involvement in Patients With Posttransplant Lymphoproliferative Disorder

Andrew S. Cho, MD; Gary N. Holland, MD; Ben J. Glasgow, MD; Sherwin J. Isenberg, MD; Barbara L. George, MD; Sue V. McDiarmid, MD

Arch Ophthalmol. 2001;119:183-189.

Objectives  To describe ocular disease in 3 patients with posttransplant lymphoproliferative disorder (PTLD) and to identify the frequency of such ocular involvement.

Methods  Medical record reviews. Using Kaplan-Meier analysis, we calculated the frequency of ocular involvement among pediatric patients with systemic PTLD after liver transplantation.

Results  Each patient had bilateral anterior chamber cells. Biopsy of an iris nodule from a patient who had undergone cardiac transplantation confirmed the diagnosis of PTLD, but no signs of systemic PTLD were found. The other 2 patients had systemic PTLD after liver transplantation; 1 presented with iris nodules in both eyes and a subretinal mass in the left eye, while the other had bilateral anterior chamber cells only. Ocular signs improved slowly after reduction of immunosuppressive drug therapy. Ophthalmological examinations were performed on 22 of 25 pediatric patients with PTLD after liver transplantation; 2 had ocular disease. Kaplan-Meier analysis indicated a 20% risk of ocular involvement at 3 years after development of PTLD (95% confidence intervals, 0%-50%).

Conclusions  Posttransplant lymphoproliferative disorder should be considered in the differential diagnosis of uveitis after organ transplantation. Anterior chamber cells and iris nodules are the most common ocular signs, but the posterior segment can be involved. Ocular involvement can occur without evidence of systemic disease and can be asymptomatic. Reduction of immunosuppressive drug therapy is an appropriate treatment.


From the University of California, Los Angeles, Ocular Inflammatory Disease Center, the Jules Stein Eye Institute, and the Department of Ophthalmology (Drs Cho, Holland, Glasgow, and Isenberg); and the Departments of Pathology (Dr Glasgow) and Pediatrics (Drs George and McDiarmid), University of California, Los Angeles, School of Medicine.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Ophthalmology Reader's Choice: Continuing Medical Education
Arch Ophthalmol. 2001;119(2):315-316.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ocular complications in heart, lung and heart-lung recipients
Akerele and Lightman
Br J Ophthalmol 2007;91:310-312.
ABSTRACT | FULL TEXT  

Post-transplantation swelling of the lower eyelid
Koenig et al.
Nephrol Dial Transplant 2004;19:1001-1003.
FULL TEXT  

Iris nodules associated with infectious uveitis
Myers et al.
Br J Ophthalmol 2002;86:969-974.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.